Aflatounian, A., Edwards, M. C., Rodriguez Paris, V., Bertoldo, M. J., Desai, R., Gilchrist, R. B., Ledger, W. L., Handelsman, D. J., & Walters, K. A. (2020). Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model. Journal of Endocrinology, 245, 381–395.
Article CAS PubMed Google Scholar
Baumann, A., Nier, A., Hernández-Arriaga, A., Brandt, A., Lorenzo Pisarello, M. J., Jin, C. J., Pilar, E., Camarinha-Silva, A., Schattenberg, J. M., & Bergheim, I. (2021). Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease. Scientific Reports, 11, 17815.
Article CAS PubMed PubMed Central Google Scholar
Bokulich, N. A., Kaehler, B. D., Rideout, J. R., Dillon, M., Bolyen, E., Knight, R., Huttley, G. A., & Gregory Caporaso, J. (2018). Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome, 6, 90.
Article PubMed PubMed Central Google Scholar
Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2018). QIIME 2: Reproducible, interactive, scalable, and extensible microbiome data science. PeerJ Preprints, 6, e27295v2.
Brennan, C. A., & Garrett, W. S. (2016). Gut microbiota, inflammation, and colorectal cancer. Annual Review of Microbiology, 70, 395–411.
Article CAS PubMed PubMed Central Google Scholar
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J., & Holmes, S. P. (2015). DADA2: High resolution sample inference from amplicon data. bioRxiv. https://doi.org/10.1101/024034
Chang, Z. P., Deng, G. F., Shao, Y. Y., Xu, D., Zhao, Y. N., Sun, Y. F., Zhang, S. Q., Hou, R. G., & Liu, J. J. (2021). Shaoyao-Gancao Decoction ameliorates the inflammation state in polycystic ovary syndrome rats via remodeling gut microbiota and suppressing the TLR4/NF-κB pathway. Frontiers in Pharmacology, 12, 670054.
Article CAS PubMed PubMed Central Google Scholar
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012). The impact of the gut microbiota on human health: An integrative view. Cell, 148, 1258–1270.
Article CAS PubMed PubMed Central Google Scholar
Cuccherini, B., Chua, K., Gill, V., Weir, S., Wray, B., Stewart, D., Nelson, D., Fuss, I., & Strober, W. (2000). Bacteremia and skin/bone infections in two patients with X-linked agammaglobulinemia caused by an unusual organism related to Flexispira/Helicobacter species. Clinical Immunology, 97, 121–129.
Article CAS PubMed Google Scholar
Diamanti-Kandarakis, E., Papailiou, J., & Palimeri, S. (2006). Hyperandrogenemia: Pathophysiology and its role in ovulatory dysfunction in PCOS. Pediatric Endocrinology Reviews, 3, 198–204.
Franik, S., Kremer, J. A., Nelen, W. L., & Farquhar, C. (2014). Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, 2, CD010287. https://doi.org/10.1002/14651858.cd010287.pub2
Gomes, A. C., Hoffmann, C., & Mota, J. F. (2018). The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes, 9, 308–325.
CAS PubMed PubMed Central Google Scholar
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011). Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nature Reviews Endocrinology, 7, 219–231.
Article CAS PubMed Google Scholar
Guo, Y., Qi, Y., Yang, X., Zhao, L., Wen, S., Liu, Y., & Tang, L. (2016). Association between polycystic ovary syndrome and gut microbiota. PLoS ONE, 11, e0153196.
Article PubMed PubMed Central Google Scholar
Guo, J., Shao, J., Yang, Y., Niu, X., Liao, J., Zhao, Q., Wang, D., Li, S., & Hu, J. (2021). Gut microbiota in patients with polycystic ovary syndrome: A systematic review. Reproductive Sciences, 29, 69–83.
Hayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015). Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nature Communications, 6, 7502.
Article CAS PubMed Google Scholar
He, Y., Wang, Q., Li, X., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2020). Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota. Food & Function, 11, 5192–5204.
Insenser, M., Murri, M., Del Campo, R., Martínez-García, M. Á., Fernández-Durán, E., & Escobar-Morreale, H. F. (2018). Gut microbiota and the polycystic ovary syndrome: Influence of sex, sex hormones, and obesity. Journal of Clinical Endocrinology and Metabolism, 103, 2552–2562.
Jobira, B., Frank, D. N., Pyle, L., Silveira, L. J., Kelsey, M. M., Garcia-Reyes, Y., Robertson, C. E., Ir, D., Nadeau, K. J., & Cree-Green, M. (2020). Obese adolescents with PCOS have altered biodiversity and relative abundance in gastrointestinal microbiota. Journal of Clinical Endocrinology and Metabolism, 105, e2134–e2144.
Article PubMed PubMed Central Google Scholar
Jumpertz, R., Le, D. S., Turnbaugh, P. J., Trinidad, C., Bogardus, C., Gordon, J. I., & Krakoff, J. (2011). Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. The American Journal of Clinical Nutrition, 94, 58–65.
Article CAS PubMed PubMed Central Google Scholar
Kafali, H., Iriadam, M., Ozardali, I., & Demir, N. (2004). Letrozole-induced polycystic ovaries in the rat: A new model for cystic ovarian disease. Archives of Medical Research, 35, 103–108.
Article CAS PubMed Google Scholar
Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018). Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: A systematic review and meta-regression. Human Reproduction Update, 24, 455–467.
Article CAS PubMed Google Scholar
La Marca, A., Egbe, T. O., Morgante, G., Paglia, T., Ciani, A., & De Leo, V. (2000). Metformin treatment reduces ovarian cytochrome P-450c17α response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome. Human Reproduction, 15, 21–23.
Lee, C. J., Sears, C. L., & Maruthur, N. (2020). Gut microbiome and its role in obesity and insulin resistance. Annals of the New York Academy of Sciences, 1461, 37–52.
Li, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013). Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nature Communications, 4, 2384.
Li, X., Feng, Y., Lin, J. F., Billig, H., & Shao, R. (2014). Endometrial progesterone resistance and PCOS. Journal of Biomedical Science, 21, 2.
Article PubMed PubMed Central Google Scholar
Li, N., Li, Y., Qian, C., Liu, Q., Cao, W., Ma, M., He, R., Chen, R., Geng, R., & Liu, Y. (2021). Dysbiosis of the saliva microbiome in patients with polycystic ovary syndrome. Frontiers in Cellular and Infection Microbiology, 10, 624504.
Article PubMed PubMed Central Google Scholar
Lin, H., An, Y., Tang, H., & Wang, Y. (2019). Alterations of bile acids and gut microbiota in obesity induced by high fat diet in rat model. Journal of Agricultural and Food Chemistry, 67, 3624–3632.
Article CAS PubMed Google Scholar
Lin, W., Wen, L., Wen, J., & Xiang, G. (2021). Effects of sleeve gastrectomy on fecal gut microbiota and short-chain fatty acid content in a rat model of polycystic ovary syndrome. Frontiers in Endocrinology, 12, 747888.
Article PubMed PubMed Central Google Scholar
Lindheim, L., Bashir, M., Münzker, J., Trummer, C., Zachhuber, V., Leber, B., Horvath, A., Pieber, T. R., Gorkiewicz, G., Stadlbauer, V., et al. (2017). Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): A pilot study. PLoS ONE, 12, e0168390.
Article PubMed PubMed Central Google Scholar
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016). Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility, 106, 6–15.
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015). Metformin and lifestyle modification in polycystic ovary syndrome: Systematic review and meta-analysis. Human Reproduction Update, 21, 560–574.
Article CAS PubMed Google Scholar
Palomba, S., de Wilde, M. A., Falbo, A., Koster, M. P., La Sala, G. B., & Fauser, B. C. (2015). Pregnancy complications in women with polycystic ovary syndrome. Human Reproduction Update, 21, 575–592.
Pichette, J., Fynn-Sackey, N., & Gagnon, J. (2017). Hydrogen sulfide and sulfate prebiotic stimulates the secretion of GLP-1 and improves glycemia in male mice. Endocrinology, 158, 3416–3425.
Article CAS PubMed Google Scholar
Piparva, K. G., & Buch, J. G. (2011). Deep vein thrombosis in a woman taking oral combined contraceptive pills. Journal of Pharmacology & Pharmacotherapeutics, 2, 185–186.
Qi, X., Yun, C., Sun, L., Xia, J., Wu, Q., Wang, Y., Wang, L., Zhang, Y., Liang, X., Wang, L., et al. (2019). Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome. Nature Medicine, 25, 1225–1233.
Comments (0)